The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $0.42 in the prior trading day, Aspire Biopharma Holdings Inc (NASDAQ: ASBP) closed at $0.36, down -15.33%. In other words, the price has decreased by -$15.33 from its previous closing price. On the day, 0.57 million shares were traded. ASBP stock price reached its highest trading level at $0.45 during the session, while it also had its lowest trading level at $0.3298.
Ratios:
Our goal is to gain a better understanding of ASBP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.00 and its Current Ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASBP now has a Market Capitalization of 17555458 and an Enterprise Value of 159989184.
Stock Price History:
The Beta on a monthly basis for ASBP is 0.91, which has changed by -0.9678977 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, ASBP has reached a high of $15.80, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -58.65%, while the 200-Day Moving Average is calculated to be -95.89%.
Shares Statistics:
The stock has traded on average 536.34K shares per day over the past 3-months and 172990 shares per day over the last 10 days, according to various share statistics. A total of 48.90M shares are outstanding, with a floating share count of 36.97M. Insiders hold about 24.39% of the company’s shares, while institutions hold 2.01% stake in the company. Shares short for ASBP as of 1744675200 were 144801 with a Short Ratio of 0.27, compared to 1741910400 on 407622. Therefore, it implies a Short% of Shares Outstanding of 144801 and a Short% of Float of 0.42.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
